TAP2 and neoplasm: STING agonists are verified to induce tumor cells apoptosis, allowing the leak of antigen-presenting molecules such as TAP1, TAP2, and MHC-I via the upregulation of IFN to further cross-prime anti-tumor T-cells and enhance immunosurveillance of tumors (63, 146, 152, 197).